Download Citation
Article Source:
Clinical role, optimal timing and frequency of serum infliximab and anti-infliximab antibody level measurements in patients with inflammatory bowel disease
Bor R,
Farkas K,
Fábián A,
Bálint A,
Milassin Á,
et al.
(2017)
Clinical role, optimal timing and frequency of serum infliximab and anti-infliximab antibody level measurements in patients with inflammatory bowel disease.
PLOS ONE 12(3): e0172916.
https://doi.org/10.1371/journal.pone.0172916